The OncoLog collection is a historical collection from The University of Texas MD Anderson Cancer Center's Department of Scientific Publications. These documents are meant to be used as historical records and not to be considered for health care decisions.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.
-
OncoLog, Volume 56, Number 06, June 2011
John H. McCool and Sunni Hoseman
- MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
- Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients
-
OncoLog, Volume 56, Number 02, February 2011
Joe Munch and John LeBas
- Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
- Screen Guidelines in Brief
- Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
- House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
- in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression
-
OncoLog, Volume 56, Number 09, September 2011
Joe Munch and Bryan Tutt
- Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide
- New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977
- HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often
- IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients
-
OncoLog, Volume 56, Number 07, July 2011
Kate Newberry and Joe Munch
- A New Era in Treating Patients Who Have Multiple Myeloma: During the past decade, several novel treatments have extended the median survival time for patients with multiple myeloma from less than 3 years to more than 7 years, and researchers are working to further improve treatment
- Landmark Trial Shows Potential of Low-Dose Computed Tomography for Lung Cancer Screening
- HOUSE CALL: Eating Healthier May Reduce Cancer Risk: Healthy eating habits may also increase energy and heart health
- IN BRIEF: Inotuzumab Ozogamicin Shows Promise for Acute Lymphoblastic Leukemia Treatment
-
OncoLog, Volume 56, Number 01, January 2011
Bryan Tutt and Sunni Hosemann
- New Drug Control Symptoms of Myeloproliferative Disorders and Improve Quality of Life for Patients: Recent clinical trials have demonstrated that a new class of drugs can effectively treat myeloproliferative disorders
- Compass: Metastatic Melanoma: Experimental treatments could be preferable to standard therapies for metastatic melanoma
- HOUS CALL: Breast Awareness: Guidelines recommend breast awareness rather than formal self-exams
-
OncoLog, Volume 56, Number 10, October 2011
Bryan Tutt and Sunni Hosemann
- Treating Cancer in Pregnant Patients: Pregnancy is usually a joyous, hopeful time; a cancer diagnosis can be devastating. When pregnancy and cancer occur together, they present special challenges for patients and physicians. Fortunately, these challenges often can be overcome by a multidisciplinary approach to treatment
- Compass: Non-Small Cell Lung Cancer: Stage IIIA-Many factors affect treatment sequences
- HOUSE CALL: Understanding Cancer Risk and Risk Factors: Your risk factors might affect your need for cancer screening
-
OncoLog, Volume 56, Number 03, March 2011
Bryan Tutt and Joe Munch
- Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
- Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
- MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
- HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines offer similar physical and psychological benefits: In the shadow of their New Year's resolutions, many people seek out the gym to improve their physical and mental well-being/ Differences and similarities/ Benefits of mind-body exercise
-
OncoLog Volume 55, Number 10, October 2010
Sunni Hoseman and Stephanie Deming
- Protecting the Patient during Radiation Theraphy: Staff expertise and equipment accuracy are essential to safe and effective treatment
- Compass Fall 2010: Stage II Colon Cancer: Adjuvant Therapy? After Surgery, some patients benefit from chemotherapy
- HOUSE CALL: Managing Cancer-Related Pain
- INBRIEF: Researchers identify Enzyme Involved in Chemotherapy Resistance
-
OncoLog Volume 55, Number 06, June 2010
John LeBas
- The BATTLE Results Are IN: Phase II trial reveals molecular signatures in lung cancer that may guide treatment decisions.
- Endoscopic Repair of Colon Perforations: Nonsurgical techniques for closing gestrointestinal defects may yiels benefits for patients undergoing colonoscopy.
- INBRIEF: Stem Cells Seen Repairing Heart Attack Damage Over Time/Additional Blood Data May Improve Pediatric Leukemia Predictions/Pediatric Patients with Rare Tumor May benefit from Heated Chemotherapy/New Findings Refute Link Between UVA, Melanoma.
- HOUSE CALL: Skin Cancer Screening: What is It and Who Should Get It ?: Types of skin cancer/Who should be screened ?/What to expect/Self-examination: Check your skin regularly and tell your doctor about any suspicious changes
-
OncoLog Volume 55, Number 04-05, April-May 2010
John LeBas and Sunni Hoseman
- IMAGING NERVES: Tetnus Toxin Offers Promise for Neurography
- INBRIEF: Fight-or-Flight Hormones Linked to Metastasis/Drug Combination Shows Promise for Colon Cancer Chemoprevention
- Compass Spring 2010: Early Uterine Papillary Serous Carcinoma: Treatment Options Tailored to Patient and Disease Characteristcs
- House Call: Addressing the Cosmetic Effects of Breast Cancer
-
OncoLog Volume 55, Number 07, July 2010
Joe Munch and Sunni Hoseman
- Refining Approaches to Thyroid Cancer: Time-proven treatments and newer biologic agents offer hope, particularly for patirnts with advanced disease.
- Thyroid Cancer in Children.
- Compass Summer 2010: Locoregional Cancer of the Esophagus: Timimg Surgery and Other Therapies for Resectable Disease.
- HOUSE CALL: Understanding Clinical Trials
-
OncoLog Volume 55, Number 02, February 2010
Joe Munch and John LeBas
- Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
- Screen Guidelines INBRIEF
- Electronic Navigatin Biopsy for Peripheral Lung Lesion Diagnosis
- House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
- INBRIEF: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression
-
OncoLog Volume 55, Number 09, September 2010
Sunita Patterson and John LeBas
- Tiny Particales, vast Potential-Coming soon to the clinic: nanoparticles that deliver therapy straight to tumor cells, bypassing normal cells and many toxic effects
- Non-Hodgkin Lymphomas: Targeted Therapies Leading Treatment Advances
- HOUSE CALL: Writing for Wellness: Keeping a Journal
- INBRIEF: Study Shows Abnormal Cells in Blood Increase with Lung Cancer Stage
-
OncoLog Volume 55, Number 01, January 2010
Bryan Tutt and Bita Esmaeli
- Ocular Cancer: Tumors of the eye threaten sight and often indicate presence of extensive disease
- Eye Care for Cancer Patients
- Doctors Team Up to Battle Retinoblastoma
- Compass Winter 2010: Ductal Carcinoma In Situ: Choosing Treatment for a Common Group of Early, Confined Breast Cancers
- Toward Tomorrow
- House Call: Three Targets for New Year's Resolutions
-
OncoLog Volume 55, Number 08, August 2010
Bryan Tutt and John LeBas
- Therapeutic Vaccines against Cancer: Clinical trials of thrapeutic vaccines in cancer patients yield positive results
- Findings Could Altere Chronic Myelogenous Leukemia Treatment: Phase III trials show newer drugs yield better responses than imatinib
- INBRIEF: Vandetanib Shows Benefit When Combined with Docetaxel for Lung Cancer/ HPV-Positive Tumor Status Indicates Better Prognosis in Patients with Oropharyngeal Cancer
- HOUSE CALL: Understanding the Benefits and Risks of Massage
-
OncoLog Volume 55, Number 03, March 2010
Bryan Tutt and Joe Munch
- Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery.
- Preventing Bone Loss nad Fractures in Cancer Patients
- INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease
- House call: Immunotherapy:Boosting the Body's Fight Against Cancer
-
OncoLog Volume 55, Number 11-12, November-December 2010
Bryan Tutt and Joe Munch
- Desmoid Tumors: Multidiciplinary treatment for an enigmatic disease
- Endoscopic Surgery for Skull Base Tumors: Patient selection is the key to success for the minimally invasive procedure
- INBRIEF: Earlier Breast Cancer Screening Recommended for Hispanic Women/SUMO Is Important for DNA Damage Repair/Regional Care Centers Make Cancer Treatment Easily Accessible/SIK2 Plays Critical Role in Chemotherapy Resistance
- HOUSE CALL: Books Provide Comfort, Guidence, Relaxation
